Published in Arch Neurol on October 01, 2004
Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. Mov Disord (2012) 1.49
β band stability over time correlates with Parkinsonian rigidity and bradykinesia. Exp Neurol (2012) 1.16
Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's disease. AAPS J (2009) 0.99
Current status of symptomatic medical therapy in Parkinson's disease. Neurotherapeutics (2008) 0.94
Health-related quality of life as an outcome variable in Parkinson's disease. Ther Adv Neurol Disord (2012) 0.92
Surrogate outcomes in neurology, psychiatry, and psychopharmacology. Dialogues Clin Neurosci (2006) 0.83
Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference. Patient Prefer Adherence (2009) 0.81
Therapy for Parkinson's disease: what is in the pipeline? Neurotherapeutics (2014) 0.81
Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases. World J Stem Cells (2015) 0.81
Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease. J Neural Transm (Vienna) (2006) 0.80
The management of orthostatic hypotension in Parkinson's disease. Front Neurol (2013) 0.80
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo). Neuropsychiatr Dis Treat (2010) 0.79
Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options. P T (2015) 0.75
Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci U S A (1979) 72.18
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science (1983) 9.41
The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science (1989) 7.03
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology (2006) 6.86
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
Parkinson disease in twins: an etiologic study. JAMA (1999) 5.45
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008) 4.88
Five SWI genes are required for expression of the HO gene in yeast. J Mol Biol (1984) 4.20
Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ Health Perspect (1999) 4.07
Mutational analysis of Drosophila synaptotagmin demonstrates its essential role in Ca(2+)-activated neurotransmitter release. Cell (1993) 4.01
The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia (2005) 3.97
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum (1997) 3.62
The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology (2010) 3.36
Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci U S A (1994) 3.36
Phase II/III randomized trial of TCH346 in patients with ALS. Neurology (2007) 3.22
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology (2007) 2.72
Asymptomatic Chiari Type I malformations identified on magnetic resonance imaging. J Neurosurg (2000) 2.63
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology (1985) 2.58
The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med (1987) 2.58
Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50
Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology (2000) 2.49
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol (1998) 2.44
Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun (2003) 2.34
Aetiology of Parkinson's disease. Lancet (1984) 2.32
Fragmentation of bile duct stones by extracorporeal shock waves. A new approach to biliary calculi after failure of routine endoscopic measures. Gastroenterology (1989) 2.31
PATHOLOGICAL VARIATIONS IN BLOOD AND SPINAL FLUID PYRUVIC ACID. J Clin Invest (1942) 2.27
Volunteering for early phase gene transfer research in Parkinson disease. Neurology (2006) 2.27
Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol (1999) 2.26
Granulocytic sarcoma in childhood leukemia: imaging features. Radiology (1994) 2.26
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008) 2.25
Unitary Ca2+ current through cardiac ryanodine receptor channels under quasi-physiological ionic conditions. J Gen Physiol (1999) 2.22
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology (2004) 2.18
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology (2002) 2.17
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Smoking and Parkinson's disease in twins. Neurology (2002) 2.15
Calcium dependence of neurotransmitter release and rate of spontaneous vesicle fusions are altered in Drosophila synaptotagmin mutants. Proc Natl Acad Sci U S A (1994) 2.15
The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging (1999) 2.11
Target genes and regulatory domains of the GAMYB transcriptional activator in cereal aleurone. Plant J (1999) 2.11
Parametric manipulation of conflict and response competition using rapid mixed-trial event-related fMRI. Neuroimage (2003) 2.10
Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation (2001) 2.03
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) (2007) 2.02
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med (1992) 2.01
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia (2004) 1.97
Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol (1997) 1.94
Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology (2001) 1.94
Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol (2001) 1.91
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology (2002) 1.90
Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization. N Engl J Med (1965) 1.87
A DNA antigen that reacts with antisera to cardiolipin. Biochem Biophys Res Commun (1974) 1.84
Pulmonary embolectomy: a 20-year experience at one center. Ann Thorac Surg (1991) 1.82
Granulocyte apoptosis and the control of inflammation. Philos Trans R Soc Lond B Biol Sci (1994) 1.75
Accidents and acts of God: a history of the terms. Am J Public Health (1996) 1.75
The hypothalamus in Parkinson disease. Ann Neurol (1978) 1.74
Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med (2000) 1.74
American Academy of Pediatrics. Pediatric Practice Action Group and Task Force on Medical Informatics. Privacy protection and health information: patient rights and pediatrician responsibilities. Pediatrics (1999) 1.73
Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res (1984) 1.71
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology (2006) 1.69
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Novel observations with FDOPA-PET imaging after early nigrostriatal damage. Mov Disord (2001) 1.68
Selegiline and mortality in Parkinson's disease. Ann Neurol (1996) 1.67
Hyperaluminaemia from aluminum resins in renal failure. Lancet (1970) 1.64
Production of 1,2-diacylglycerol and phosphatidate in human erythrocytes treated with calcium ions and ionophore A23187. Biochem J (1976) 1.63
Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol (1993) 1.61
rop, a Drosophila homolog of yeast Sec1 and vertebrate n-Sec1/Munc-18 proteins, is a negative regulator of neurotransmitter release in vivo. Neuron (1994) 1.60
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes (1992) 1.60
Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Can J Neurol Sci (1984) 1.57
Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol (1986) 1.56
Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. J Immunol (1988) 1.54
An unusual cause of blindness in Wegener's granulomatosis. Rheumatology (Oxford) (1999) 1.54
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism. J Neurol Neurosurg Psychiatry (2000) 1.49
Update in Sjögren syndrome. Curr Opin Rheumatol (2000) 1.47
Transference-countertransference: realizing a love by not actualizing it. Isr J Psychiatry Relat Sci (1994) 1.46
Quantitative gas-liquid chromatographic analysis of rodent milk triglycerides. J Lipid Res (1968) 1.45
Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J Biol Chem (1995) 1.45
Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res (1988) 1.44
Levodopa induces dyskinesias in normal squirrel monkeys. Ann Neurol (2001) 1.44
Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology (2003) 1.44
Parkinsonism caused by petroleum waste ingestion. Neurology (1994) 1.42
PCR analysis of platelet mtDNA: lack of specific changes in Parkinson's disease. Mov Disord (1993) 1.42
The effect of early insertion of grommets on the development of speech in children with cleft palates. Br J Oral Maxillofac Surg (2007) 1.41
(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA (1988) 1.41
Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med (1983) 1.40
[Continuous high-dose corticosteroid pressured aerosol therapy in steroid-dependent asthma]. Presse Med (1989) 1.39
Tremor in MPTP-induced parkinsonism. Neurology (1992) 1.39
Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros (2002) 1.38
Mutations in the Drosophila pushover gene confer increased neuronal excitability and spontaneous synaptic vesicle fusion. Genetics (1996) 1.38
Selegiline and Parkinson's disease: it's déjà vu-again. Neurology (2000) 1.37
High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol (1997) 1.36
Influenza and asthma. Lancet (1992) 1.35
Pollen carbohydrates and water content during development, presentation, and dispersal: a short review. Protoplasma (2006) 1.34
Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging (2000) 1.31
Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg (1991) 1.30
The effect of deprenyl and levodopa on the progression of Parkinson's disease. Ann Neurol (1995) 1.29
A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol Carcinog (1997) 1.27
Immunochemical measurement of myelin basic protein in developing rat brain: an index of myelin synthesis. Dev Biol (1976) 1.27
Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology (2005) 1.25